Effective headache management

Postgraduate Medicine

Volumn 104, Issue 5, 1998, Pages 133-147

  Jackson, Christy M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYPROHEPTADINE; FLUOXETINE; INDOCHRON; INDOMETACIN; KETOPROFEN; LITHIUM CARBONATE; METHYSERGIDE MALEATE; METOPROLOL; METOPROLOL TARTRATE; NADOLOL; NAPROXEN; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PAROXETINE; PROPRANOLOL; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TIMOLOL MALEATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROATE SEMISODIUM; VERAPAMIL;

ARTICLE; CLUSTER HEADACHE; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; HEADACHE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; TENSION HEADACHE;

EID: 0031759420     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.11.406     Document Type: Article

References (22)

1. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 1992;267(1):64-9
2. Lipton RB, Stewart WF, Celentano DD, et al. Undiagnosed migraine headaches: a comparison of symptom-based and reported physician diagnosis. Arch Intern Med 1992;152(6):1273-8
3. Celentano DD, Stewart WF, Lipton RB, et al. Medication use and disability among migraineurs: a national probability sample survey. Headache 1992;32(5):223-8
4. Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994;44(7):1353-4
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7): 1-96
6. Raskin NH. Headache. 2d ed. New York: Churchill Livingstone, 1988
7. Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964; 42(Jun):1236-9
8. Kudrow L. Cluster headache: mechanisms and management. New York: Oxford University Press, 1980
9. Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache 1981;21(1):1-4
10. Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991; 325(5):322-6
11. Kittrelle JP, Grouse DS, Seybold ME. Cluster headache: local anesthetic abortive agents. Arch Neurol 1985;42(5):496-8
12. Evers S, Bauer B, Suhr B, et al. Cognitive processing in primary headache: a study on event-related potentials. Neurology 1997:48(1):108-13
13. Wang W, Schoenen J, Timsit-Berthier M. Cognitive functions in migraine without aura between attacks: a psychophysiological approach using the "oddball" paradigm. Neurophysiol Clin 1995;25(1):3-11
14. Wolff HG. Headache and other head pain. 2d ed. New York: Oxford University Press, 1963
15. Moskowitz MA. The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991; 41(2 Pt 1):182-6
16. Lance JW, Lambert GA, Goadsby PJ, et al. Contribution of experimental studies to understanding the pathophysiology of migraine. In: Sandler M, Collins GM, eds. Migraine, a spectrum of ideas. New York: Oxford University Press, 1990:21-39
17. Goadsby PJ, Zagami AS, Donnan GA, et al. Oral sumatriptan in acute migraine. Lancet 1991;338(8770):782-3
18. Cady RK, Wendt JK, Kirchner JR, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265(21):2831-5
19. Tfelt-Hansen P, Henry P, Mulder LJ, et al. [The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks: a randomized, double-blind, placebo-controlled clinical trial.] Ugeskr Laeger 1996;158(45):6435-9 (Dan)
20. Teall J, Tuchman M, Cutler N, et al. Rizatriptan (Maxalt) for the acute treatment of migraine and migraine recurrence: a placebo-controlled, outpatient study. Headache 1998:38(4):281-7
21. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52(3):281-6
22. Kaniecki RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol 1997;54(9):1141-5